Jeffrey Tyner, Ph.D.

Head Shot of Jeffrey Tyner
click here

Selected Publications

"Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia," Clinical Cancer Research (Vol: 20, Issue: 8, Page 2092-2103) - 2014

"Corepressor Rcor1 is essential for murine erythropoiesis," Blood (Vol: 123, Issue: 20, Page 3175-3184) - 2014

"Functional genomics for personalized cancer therapy," Science Translational Medicine (Vol: 6, Issue: 243, ) - 2014

"Functional integration of acute myeloid leukemia into the vascular niche," Leukemia - 2014

"Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization," Journal of Biological Chemistry (Vol: 289, Issue: 9, Page 5820-5827) - 2014



  Email Jeffrey Tyner

503 346-0603